Immunome, Inc.

NASDAQ:IMNM

12.54 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 2.3641.0293.8263.5654.2632.3640000000000000000
Kosten van de omzet 0.6730.2630.2570.1660.1570.1480.260.1140.1210.1360.1180.2860.1750.17600000000
Brutowinst 1.6910.7663.5693.3994.1062.216-0.26-0.114-0.121-0.136-0.118-0.286-0.175-0.17600000000
Brutowinstmarge 0.7150.7440.9330.9530.9630.9370000000000000000
Onderzoek- en ontwikkelingskosten 34.722127.0690.1823.8235.7163.9134.2525.2255.7178.0784.3854.5133.2331.9791.8351.6441.8922.1152.4322.2342.0792.079
Algemene en administratieve kosten 6.9786.0058.044.3754.322.9223.5353.3093.2093.5763.4593.212.5071.9182.2381.1740.8230.540.4560.4860.2920.292
Verkoop- en marketingkosten 00-00000000000000000000
Verkoop-, algemene en administratieve kosten 6.9786.0058.044.3754.322.9223.5353.3093.2093.5763.4593.212.5071.9182.2381.1740.8230.540.4560.4860.2920.292
Overige kosten 29.08315.36923.0890000000-0.0030.0060.5000000000
Bedrijfskosten 41.7133.06598.2228.19810.0366.8357.7878.5348.92611.6547.8447.7235.743.8974.0732.8182.7152.6552.8882.722.372.37
Bedrijfsresultaat -40.009-132.299-94.653-4.633-5.773-4.471-7.787-8.534-8.926-11.654-7.844-7.723-5.74-3.897-4.073-2.818-2.715-2.655-2.888-2.72-2.37-2.37
Bedrijfsresultaat ratio -16.924-128.571-24.739-1.3-1.354-1.8910000000000000000
Totaal overige inkomsten en kosten netto 3.8872.8072.0190.2880.2160.2010.0010.0010.0020.001-0.0030.0060.5-0.0010.011-5.5490.005-0.022-0.034-0.017-0.023-0.023
Inkomen voor belasting -36.122-129.492-92.634-4.345-5.557-4.27-7.786-8.533-8.924-11.653-7.852-7.72-5.241-3.898-4.073-8.377-2.71-2.677-2.922-2.737-2.393-2.393
Inkomen voor belasting ratio -15.28-125.843-24.212-1.219-1.304-1.8060000000000000000
Belastingkosten 0-00.367-0.1660.035-0.2010.618-0.001-0.002-0.0010.0060.0090.0010-0.2450.01000.01000
Nettowinst -36.122-129.492-92.634-4.345-5.557-4.069-8.404-8.532-8.922-11.652-7.852-7.72-5.241-3.898-4.073-8.377-2.71-2.677-2.922-2.737-2.393-2.393
Nettowinstmarge -15.28-125.843-24.212-1.219-1.304-1.7210000000000000000
WPA (Winst Per Aandeel) -0.6-12.56-4.22-0.36-0.46-0.33-0.69-0.7-0.74-0.96-0.66-0.65-0.46-0.37-0.4-0.83-0.29-0.47-0.51-0.48-2.19-2.19
Verwaterde WPA -0.6-12.56-4.22-0.36-0.46-0.33-0.69-0.7-0.74-0.96-0.66-0.65-0.46-0.37-0.4-0.83-0.29-0.47-0.51-0.48-2.19-2.19
EBITDA -39.336-132.036-94.396-4.633-5.616-4.471-7.527-8.42-8.805-11.518-7.729-7.431-5.565-3.721-4.073-2.641-2.556-2.492-2.717-2.566-2.22-2.22
EBITDA ratio -16.64-128.315-24.672-1.3-1.317-1.8910000000000000000